Cyclosporine Eye Drops: Complete Guide
Updated: Sep 9
Written by Dr. Charles Drew, Lead Pharmaceutical Content Specialist & Clinical Drug Information Reviewer
Reviewed for medical accuracy under the Ivermectinkart Editorial Policy
Introduction
Dry eye can feel deceptively simple—burning, grittiness, fluctuating vision, or the constant need for artificial tears—but persistent symptoms may involve inflammation of the eye surface. Cyclosporine eye drops are prescription medicines designed to address this inflammatory component rather than simply adding temporary lubrication. In the United States, several topical cyclosporine formulations are approved for dry eye-related indications, although their concentrations, formulations, and exact FDA-approved uses differ. Research shows that topical cyclosporine can improve important dry-eye signs, while improvement in symptoms varies among patients. This guide explains how cyclosporine works, who may receive it, available formulations, proper use, expected treatment timelines, side effects, and important safety considerations.
What Are Cyclosporine Eye Drops and How Do They Work?
Cyclosporine eye drops are prescription anti-inflammatory medicines used to manage certain ocular-surface conditions, particularly dry eye disease. Cyclosporine belongs to a drug class called calcineurin inhibitors and has immunomodulating effects, meaning it changes specific immune activity involved in inflammation.
Dry eye is not always simply a shortage of tears. In some people, inflammation of the ocular surface—the cornea, conjunctiva, and related tear-producing system—contributes to an unstable tear film and ongoing symptoms.
Topical cyclosporine helps interrupt this inflammatory process. Depending on the particular formulation, the treatment may improve tear production, ocular-surface staining, or other signs and symptoms of dry eye disease. FDA-approved indications are formulation-specific and should not be assumed to be identical across products.
This distinction matters because artificial tears and cyclosporine do different jobs. Lubricating drops primarily supplement or stabilize the tear film, whereas cyclosporine targets inflammation involved in the disease process.
Cyclosporine eye drops are not simply stronger artificial tears. They are prescription anti-inflammatory treatments intended to modify an underlying inflammatory component of ocular-surface disease, so benefits may develop gradually rather than immediately.
What Are Cyclosporine Eye Drops Used For?
In the United States, topical cyclosporine is principally associated with prescription treatment of dry eye disease, but the exact approved indication depends on the product. For example, CEQUA 0.09% is FDA-approved to increase tear production in people with keratoconjunctivitis sicca, while VEVYE 0.1% is indicated for treatment of the signs and symptoms of dry eye disease.
Dry eye disease
Dry eye disease can occur when the eyes do not produce adequate tears, tears evaporate too quickly, or the tear film does not function normally. Inflammation can become part of a cycle in which ocular-surface irritation promotes further tear-film instability and inflammation.
Symptoms can include:
Burning or stinging
A gritty or sandy sensation
Eye redness or irritation
Sensitivity to light
Blurred or fluctuating vision
Eye fatigue
Excessive watering, which can paradoxically occur when the surface is irritated
Difficulty tolerating contact lenses
These symptoms are not specific to dry eye. Persistent eye discomfort or visual changes deserve an eye examination rather than self-diagnosis.
Other ocular-surface conditions
Cyclosporine is also used in ophthalmology for conditions beyond routine dry eye management. Importantly, whether a particular use is FDA-approved depends on the formulation and condition.
One clear example is Verkazia, a cyclosporine ophthalmic emulsion approved in the United States for vernal keratoconjunctivitis, an inflammatory eye disorder, in children and adults. FDA information on cyclosporine for vernal keratoconjunctivitis confirms this specific approval.
Cyclosporine has been studied or used in additional ocular-surface disorders, but that does not automatically mean every cyclosporine product is FDA-approved for those conditions. Treatment outside an approved indication is considered off-label and requires clinical judgment.
Which Cyclosporine Eye Drop Formulations Are Available?
Cyclosporine ophthalmic products are not interchangeable simply because they contain the same active drug. Concentration, formulation technology, approved indication, packaging, administration instructions, and tolerability can differ.
Examples of prescription cyclosporine eye-drop formulations used in the United States
Formulation | Cyclosporine concentration | FDA-labeled role | Typical labeled frequency |
Restasis | 0.05% | Increase tear production when tear production is presumed to be suppressed by inflammation associated with keratoconjunctivitis sicca | Twice daily, about 12 hours apart |
Cequa | 0.09% | Increase tear production in patients with keratoconjunctivitis sicca | Twice daily, about 12 hours apart |
Vevye | 0.1% | Treat signs and symptoms of dry eye disease | Twice daily, about 12 hours apart |
Verkazia | Different formulation/indication | Treatment of vernal keratoconjunctivitis in children and adults | Follow its product-specific prescribing instructions |
Restasis 0.05%, Cequa 0.09%, and Vevye 0.1% use different drug-delivery formulations. A higher percentage therefore should not be interpreted as automatically being “stronger” or better for a particular patient.
A network meta-analysis evaluating several commercial cyclosporine formulations found that formulation differences may influence particular outcomes, but the evidence does not support reducing product choice to concentration alone.
For practical purposes, the best formulation is the one selected by an eye-care professional based on the diagnosis, treatment goals, previous therapies, tolerability, access, and product-specific prescribing information.
How Effective Are Cyclosporine Eye Drops for Dry Eye?
Cyclosporine has substantial clinical evidence supporting its use in dry eye disease, particularly for improving objective signs of ocular-surface disease. However, symptom improvement is less consistent, and individual response varies.
A 2025 systematic review of topical prescription treatments found that randomized trials more consistently demonstrated improvements in dry-eye signs—such as corneal staining or tear-production measurements—than in symptoms such as dryness or discomfort. systematic review of topical dry eye treatments provides broader evidence on prescription treatments, including cyclosporine.
An additional 2025 systematic review and meta-analysis found improvements in ocular-surface symptoms and staining with topical cyclosporine, but researchers rated the overall certainty of evidence as low to moderate because of factors including imprecision and risk of bias.
What does the evidence say about different concentrations?
Older evidence for cyclosporine 0.05% is substantial. A systematic review of 12 randomized controlled trials involving 1,367 participants found improvements in several clinical and patient-reported dry-eye outcomes compared with controls, although adverse effects occurred more frequently in cyclosporine-treated participants.
More recent evidence also supports 0.1% formulations. A 2025 meta-analysis of six randomized trials involving 2,170 patients found improvements in measures including corneal and conjunctival staining and Ocular Surface Disease Index scores compared with vehicle treatment. Reported adverse events were generally mild to moderate.
The practical message is that cyclosporine is an evidence-supported dry-eye treatment, but no concentration guarantees a particular result for an individual.
How Do You Use Cyclosporine Eye Drops Correctly?
Cyclosporine eye drops should be used according to the exact instructions for the prescribed product. Several U.S. formulations are labeled for twice-daily administration approximately 12 hours apart, but patients should follow their prescription rather than applying instructions from another cyclosporine product.
A general eye-drop technique is:
Wash and dry your hands.
Prepare the container according to its product instructions.
Tilt your head back and look upward.
Gently pull the lower eyelid down to form a small pocket.
Hold the container above the eye without touching the eye, eyelashes, fingers, or surrounding skin with the tip.
Place the prescribed drop into the eye.
Close the eye gently rather than repeatedly blinking.
Recap or discard the container according to its specific instructions.
Keeping the dropper tip clean matters because touching the eye or another surface can contaminate the container or cause eye injury.
Can you use artificial tears with cyclosporine?
Often, yes. People with dry eye may continue using lubricating artificial tears while receiving prescription anti-inflammatory treatment.
The required interval between different eye medicines can depend on the cyclosporine formulation. For example, current VEVYE instructions advise waiting at least 15 minutes between VEVYE and another ophthalmic medicine. FDA instructions for VEVYE ophthalmic solution also specify product-specific administration and contact-lens precautions.
Do not assume the same interval applies to every eye medication; check the prescribing instructions or ask a pharmacist or eye-care professional.
What about contact lenses?
Contact-lens instructions are also formulation-specific. Cyclosporine should generally not be placed directly onto contact lenses when the product labeling instructs lens removal.
For example, current Restasis Multidose labeling states that lenses should be removed before administration and may be reinserted 15 minutes afterward.
Practical dos and don’ts when using prescription cyclosporine eye drops
Do | Don’t |
Follow the instructions for your exact product | Substitute another concentration or formulation on your own |
Wash your hands before administration | Touch the dropper tip to your eye, fingers, or another surface |
Use the medicine consistently as prescribed | Stop simply because improvement is not immediate |
Follow product-specific contact-lens instructions | Instill the medicine over contact lenses unless specifically directed |
Ask how to space other eye medicines | Put several ophthalmic medicines in together without checking instructions |
Report persistent or worsening reactions | Assume every episode of redness or eye pain is a normal side effect |
How Long Does Cyclosporine Take to Work?
Cyclosporine is generally a longer-term treatment rather than a rapid-relief lubricating drop. Some clinical signs can improve within weeks with certain newer formulations, but symptom improvement may take longer and varies substantially among individuals.
For example, randomized studies of water-free cyclosporine 0.1% have demonstrated improvement in corneal staining by approximately four weeks. That finding does not mean everyone will feel dramatically better within a month, because clinical signs and patient-reported symptoms do not always improve at the same rate.
This is one reason consistency matters. Stopping treatment after only a few days because the eyes still feel dry may be too early to judge a therapy intended to control chronic inflammation.
At follow-up, an eye-care professional may evaluate both how you feel and objective measures such as:
Corneal or conjunctival staining
Tear production
Tear-film stability
Eyelid and meibomian-gland health
Ocular-surface inflammation
Changes in vision or functional symptoms
Treatment duration depends on the underlying condition and response. Dry eye disease is often chronic, so some patients require ongoing management.
What Are the Side Effects and Safety Considerations?
The most common problems with topical cyclosporine are local eye reactions rather than the systemic effects associated with oral or injected cyclosporine. Burning, stinging, discomfort, redness, or pain around the time of instillation can occur, with the exact adverse-event profile varying by formulation.
For example, FDA labeling has reported ocular burning as a common adverse reaction with Restasis, instillation-site pain with Cequa, and instillation-site reactions with Vevye.
This illustrates why side-effect percentages from one formulation should not automatically be applied to another.
Pregnancy, breastfeeding, and children
Tell your prescriber if you are pregnant, planning pregnancy, or breastfeeding. Systemic exposure from ophthalmic cyclosporine is much lower than with oral cyclosporine, but pregnancy and lactation information remains product-specific.
Age approvals also differ. Some dry-eye formulations have pediatric age limitations, whereas Verkazia has an FDA-approved indication for vernal keratoconjunctivitis in children and adults.
Never use someone else's prescription eye drops for a child.
When Should You Contact an Eye-Care Professional?
Mild temporary burning or stinging can occur with cyclosporine eye drops, but significant pain, worsening vision, marked swelling, or symptoms suggesting infection should not simply be attributed to the medication.
Seek prompt professional assessment if you develop:
New or substantial loss of vision
Severe or worsening eye pain
Significant swelling around the eye
Marked or rapidly worsening redness
Pus-like or unusual discharge
Eye injury or chemical exposure
Severe light sensitivity
Symptoms of a serious allergic reaction
Also contact your prescriber if side effects repeatedly prevent you from using the medication as directed. Changing frequency, switching products, or discontinuing treatment without advice can make it difficult to determine whether the treatment is helping.
Persistent dry-eye symptoms also deserve reassessment. Dry eye has several possible contributors—including meibomian-gland dysfunction, medications, autoimmune disease, environmental exposure, eyelid abnormalities, and other ocular-surface conditions—so cyclosporine will not necessarily address every cause.
Conclusion
Cyclosporine eye drops are prescription anti-inflammatory treatments that can improve important signs of dry eye disease and, for some patients, symptoms as well. Different formulations have different concentrations, delivery systems, FDA-approved indications, administration instructions, and side-effect profiles, so they should not be treated as interchangeable products. Improvement may be gradual, making correct and consistent use important.
If persistent dryness, burning, redness, or fluctuating vision is affecting daily life, an eye-care professional can determine whether inflammation is contributing and whether prescription treatment is appropriate. This guide is educational and does not replace diagnosis, prescribing advice, or the instructions supplied with your specific medication.
Frequently Asked Questions
1. Are cyclosporine eye drops steroids?
No. Cyclosporine is a calcineurin inhibitor with immunomodulating and anti-inflammatory effects, not a corticosteroid. Both drug types may be used in ocular-surface disease, but their roles, risks, treatment duration, and monitoring requirements are different.
2. Can cyclosporine eye drops cure dry eye permanently?
Not necessarily. Dry eye disease is often chronic and may have several contributing causes. Cyclosporine can help control inflammation and improve certain signs and symptoms, but some people need ongoing treatment or additional therapies.
3. Why do cyclosporine drops burn when I put them in?
Temporary burning, stinging, or instillation discomfort is a recognized adverse effect of several cyclosporine formulations. The frequency differs between products. Persistent, severe, or worsening pain should be discussed with an eye-care professional rather than assumed to be normal.
4. Can I use artificial tears while taking cyclosporine?
Usually, artificial tears can be part of dry-eye management alongside cyclosporine. However, the required spacing between products may differ by formulation. Follow the instructions for your specific prescription and ask your pharmacist or eye-care professional when uncertain.
5. How long should I use cyclosporine eye drops?
Treatment length depends on your diagnosis, formulation, response, and eye-care professional's assessment. Because dry eye disease is frequently chronic, treatment may continue for an extended period. Do not stop or alter a prescription solely because symptoms improve or improvement seems slow.
6. Is Restasis the same as cyclosporine?
Restasis is one brand formulation containing cyclosporine, but it is not the only cyclosporine ophthalmic product. Other U.S. products use different concentrations and formulations. They should not be assumed to be clinically interchangeable without guidance from the prescribing professional.
Comments